Hyperfine President and CEO Dave Scott will step down from his position effective July 29, after serving just over a year in the role.
Scott cited “personal reasons” for the decision to leave the Guilford-based company, according to an announcement. He will also no longer serve on the company’s board.
Hyperfine manufactures a compact, portable magnetic resonance imaging device called “Swoop.” It can be wheeled to a patient’s bedside and plugged into a standard wall outlet. According to the company, the technology helps make diagnosis and potential treatment of disease faster and easier than with traditional MRI machines.
“I am disappointed to have to step back from my role as president and CEO of Hyperfine,” Scott said, in a press release announcing his departure. “It has been an honor to lead the company through our first full year of commercialization and our transition to becoming a publicly listed company.”
“I have no doubt Hyperfine will continue to expand its footprint through 2022 and beyond,” he added.
The company is beginning a search for a long-term CEO to replace Scott. In the meantime, Scott Huennekens, now the executive chair of the board, will serve as interim president and CEO and will oversee the company’s ongoing expansion efforts.
Huennekens has been involved in more than 20 medtech startup, growth and public companies with market valuations totaling over $20 billion, according to Hyperfine.
“First of all, we would like to thank Dave for his tremendous contributions to Hyperfine over the last year,” Huennekens said. “He has led the expansion of our commercial efforts, taken the company public, developed plans for expanded clinical indications and built a world-class management team.”
Huennekens said the company wishes Scott well as he “addresses the personal reasons limiting his ability to continue as president and CEO of Hyperfine.”
Contact Michelle Tuccitto Sullo at msullo@newhavenbiz.com.
